Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA)

Historical Holders from Q2 2024 to Q3 2025

Symbol
KNSA on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
43,510,440
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
40,800,729
Holdings value
$1,584,103,697
% of all portfolios
0%
Number of holders
199
Number of buys
105
Number of sells
-100
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Rubric Capital Management LP 9.24% +15% $108,181,595 +$14,569,740 3,909,806 +16% RUBRIC CAPITAL MANAGEMENT LP 30 Jun 2025
VANGUARD GROUP INC 7.04% $118,941,532 3,063,135 The Vanguard Group 30 Sep 2025
TANG CAPITAL MANAGEMENT LLC 5.2% $46,556,874 2,178,609 TANG CAPITAL MANAGEMENT, LLC 28 Mar 2025
BlackRock, Inc. 1% -88% $11,570,238 -$51,021,128 418,151 -82% BlackRock, Inc. 30 Jun 2025

Institutional Holders of Kiniksa Pharmaceuticals International, plc - Common Stock (KNSA)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 40,800,729 $1,584,103,697 +$42,759,189 $38.83 199
2025 Q2 39,765,765 $1,100,293,484 +$3,474,538 $27.67 186
2025 Q1 39,936,950 $887,052,494 +$25,344,007 $22.21 173
2024 Q4 38,910,834 $769,756,202 -$20,642,445 $19.78 156
2024 Q3 39,503,444 $987,347,556 +$124,891,730 $24.99 172
2024 Q2 35,248,812 $658,014,093 +$655,780,340 $18.67 126